List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 28, Status: Authorised

List of eligible industry stakeholder organisations

Vaccines: concerns, questions and false claims

COVID-19 vaccines: key facts

Human medicines European public assessment report (EPAR): Supemtek, trivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 30/03/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 60, Status: Authorised

Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Yellox, bromfenac, Date of authorisation: 18/05/2011, Revision: 13, Status: Authorised